Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

The first in a series of Dotmatics Luma Multimodal R&D Solutions Geneious has been seamlessly composed into Luma showcasing cross-therapeutic capabilities within a unified platform BOSTON, Oct. 22, 2024 /PRNewswire/ -- Dotmatics®, a leader in R&D scientific software connecting science,...